Jazz Pharmaceuticals Bets on Cannabis-based Medicines with US$7.2 B GW Pharmaceuticals Buy

By Neha Madhwani & Michelle Liu

Pharma Deals Review: Vol 2021 Issue 3 (Table of Contents)

Published: 31 Mar-2021

DOI: 10.3833/pdr.v2021.i3.2601     ISSN: 1756-7874

Section: Mergers & Acquisitions



In its largest M&A deal to date, Jazz Pharmaceuticals has agreed to acquire GW Pharmaceuticals to expand its neuroscience portfolio...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details